RIVASTIGMINE 1.5 MG CAPSULE

RIVASTIGMINE TARTRATE
$0.3616per EA
High Outlier

Strength

1.5 mg/1

NDC

75834013305

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

10/23/2019

Active Ingredients

RIVASTIGMINE TARTRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA203844

On Market Since

9/4/2017

Pharmacological Classes

Cholinesterase Inhibitor
Cholinesterase Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

-45.9%